Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/17/23 17:11 | 2/16/23 | OCGN | Health | BioPrd | Biological Products, (No Diag | Musunuri Shankar | PA | DO | CEO | S.d | -108 | 1.08 | 0 | -100 | -3 | 3,335 | D | ||||||||||||||
1/19/23 16:12 | 1/17/23 | OCGN | Health | BioPrd | Biological Products, (No Diag | Musunuri Shankar | PA | DO | CEO | S.d | -128 | 1.28 | 0 | -100 | -3 | 3,373 | D | ||||||||||||||
12/20/22 16:07 | 12/16/22 | OCGN | Health | BioPrd | Biological Products, (No Diag | Musunuri Shankar | PA | DO | CEO | S.d | -137 | 1.43 | 0 | -96 | -5 | 1,898 | D | ||||||||||||||
10/14/22 16:15 | 10/14/22 | OCGN | Health | BioPrd | Biological Products, (No Diag | Musunuri Shankar | PA | DO | CEO | S.d | -166 | 1.66 | 0 | -100 | -5 | 1,898 | D | ||||||||||||||
10/7/22 16:06 | 10/6/22 | OCGN | Health | BioPrd | Biological Products, (No Diag | Kumar Ramesh | PA | D | S.d | -8 | 1.83 | 0 | -5 | -100 | 0 | D | |||||||||||||||
8/12/22 16:49 | 8/11/22 | OCGN | Health | BioPrd | Biological Products, (No Diag | Castillo Kirsten | PA | D | S.d | -122 | 2.91 | 0 | -42 | -46 | 50 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |